Compare VERA & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | PFS |
|---|---|---|
| Founded | 2016 | 1839 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | 2021 | 2002 |
| Metric | VERA | PFS |
|---|---|---|
| Price | $38.16 | $24.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $81.30 | $23.75 |
| AVG Volume (30 Days) | ★ 2.5M | 1.1M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.28% |
| EPS Growth | N/A | ★ 112.38 |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $73,109,000.00 |
| Revenue This Year | N/A | $0.68 |
| Revenue Next Year | $472.48 | $5.97 |
| P/E Ratio | ★ N/A | $40.18 |
| Revenue Growth | N/A | ★ 7.06 |
| 52 Week Low | $19.07 | $17.61 |
| 52 Week High | $56.05 | $24.56 |
| Indicator | VERA | PFS |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 59.55 |
| Support Level | $37.34 | $22.61 |
| Resistance Level | $38.59 | N/A |
| Average True Range (ATR) | 2.81 | 0.47 |
| MACD | -0.45 | 0.03 |
| Stochastic Oscillator | 21.33 | 70.76 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.